Hi-Tech Pharmacal has received the FDA approval for its abbreviated new drug application (ANDA) for Levetiracetam oral solution 100mg/mL, the generic for UCB Pharma's Keppra oral solution.
Subscribe to our email newsletter
Levetiracetam oral solution is used to treat partial onset seizures in people 16 years of age and older with epilepsy.
The company expects to launch the product by May 2012.
Hi-Tech currently has 14 products awaiting approval at the FDA, targeting brand and generic sales of over $1.5bn.
Hi-Tech is a specialty pharmaceutical company developing, manufacturing and marketing generic and branded prescription and OTC products.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.